|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.6 USD | -5.45% |
|
-1.14% | -36.43% |
| 05-13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
| 05-10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
Organogenesis Holdings Inc. announced the appointment of Michael J. Driscoll, Ed.D. to the Company's Board of Directors, effective February 15, 2022. Dr. Driscoll will serve as an independent director of the Company and member of the Audit Committee and the Nominating Committee of the Board. Dr. Driscoll most recently served as the dean of the Richard J. Bolte, Sr. School of Business at Mount St.
Mary's University from 2018 to 2020.
| 1st Jan change | Capi. | |
|---|---|---|
| -36.43% | 365M | |
| +48.64% | 54.63B | |
| -6.44% | 39.92B | |
| +37.07% | 38.82B | |
| +14.28% | 26.86B | |
| -11.17% | 26.22B | |
| -21.40% | 18.78B | |
| +25.64% | 12.21B | |
| +0.96% | 12.16B | |
| +27.04% | 11.94B |
ORGANOGENESIS HOLDINGS INC. 
